|ITEM METADATA RECORD
|Title: ||Effect of KRAS and NRAS mutations on treatment outcomes in patients with metastatic colorectal cancer (mCRC) treated first-line with cetuximab plus FOLFOX4: New results from the OPUS study|
|Authors: ||Tejpar, Sabine|
|Issue Date: ||2014 |
|Publisher: ||Grune & Stratton|
|Host Document: ||Journal of Clinical Oncology vol:32 issue:3|
|Conference: ||Gastrointestinal Cancers Symposium location:San Francisco: CA date:JAN 16-18, 2014|
|Publication status: ||published|
|KU Leuven publication type: ||IMa|
|Appears in Collections:||Molecular Digestive Oncology (+)|
|Files in This Item:
There are no files associated with this item.
All items in Lirias are protected by copyright, with all rights reserved.